Ginkgo Bioworks Holdings, Inc. (DNA)
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Ginkgo Bioworks Holdings, Inc. (DNA) is listed on the New York Stock Exchange, where it has traded since April 19, 2021.
- Listed On
- the New York Stock Exchange
- Listed Since
- April 19, 2021
- Employees
- 485
- Market Cap
- $897M
About Ginkgo Bioworks Holdings, Inc.
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering engaged in providing biological R&D services for customers across a range of industries and Biosecurity that provides services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 178 institutions reported holding DNA, with 35.2 million shares worth $349.3 million in aggregate. The largest reported holder was BlackRock, with 4.3 million shares worth $42.4 million. Of the 5 largest holders listed below, 3 added shares and 2 held their positions unchanged during the quarter.
| Institution | Shares | Value | Quarter change |
|---|---|---|---|
| BlackRock | 4,282,903 | $42M | Added 17.59% |
| Viking Global Investors | 3,577,128 | $35M | Unchanged |
| Vanguard | 3,383,027 | $34M | Added 20.81% |
| Erste Asset Management GMBH | 2,536,939 | $26M | Added 30.25% |
| Baillie Gifford | 2,391,649 | $24M | Unchanged |
Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.
Frequently asked questions
What is DNA?
Ginkgo Bioworks Holdings, Inc. (DNA) is listed on the New York Stock Exchange, where it has traded since April 19, 2021.
Who are the largest institutional holders of DNA?
In 13F filings for the quarter ended June 30, 2026, the largest reported holders of DNA were BlackRock, Viking Global Investors and Vanguard.
How many institutions own DNA?
178 institutions reported a position in DNA for the quarter ended June 30, 2026, worth $349.3 million in total.
Did institutions buy or sell DNA last quarter?
Of the 5 largest reported holders, 3 added shares and 2 held their positions unchanged during the quarter. Every reported holder and its change is on the SentiSense ownership page for DNA.
Every reported institutional holder, plus insider and congressional trades in DNA, on SentiSense.